tirzepatide once weekly for the treatment of obesity journal club Obesity: “Mounting” Evidence for Substantial Weight Loss Real-world Treatment Satisfaction and Experience

Sipping water throughout the day rather than consuming large amounts at once may be more comfortable

In the SURMOUNT-1 clinical trial, patients on the 15 mg dose lost an average of 22.5% of their body weight about 48 pounds over 72 weeks

Since previous studies have linked the activation of NRF2 with the repression of lipogenic gene expression 64 , we reasoned that GSH depletion causes oxidation and consequent inactivation of KEAP1 (a repressor of NRF2), thus leading to increased antioxidant and decreased lipogenic gene expression

Inspect both the tirzepatide vial and bacteriostatic water bottle for any visible cracks, cloudiness, or discoloration

Zepbound and Lipedema: What the Medication Is Really Targeting The relationship between zepbound and lipedema is often misunderstood because the medication can produce significant overall weight loss

Ikeji Brenda studied medicine at St Georges University of London and has most recently worked in John Radcliffe Oxford University Hospitals, covering acute and general medicine